Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AffinityImmuno is a Canadian biotechnology company and contract research organization (CRO) specializing in the development of antibodies and bioanalytical tools for the life sciences industry. The company offers a wide range of services, including custom antibody production, ELISA kit development, and biosimilar characterization. AffinityImmuno is recognized for its expertise in pharmacokinetics (PK) and anti-drug antibody (ADA) assays, which are critical for the development of therapeutic biologics. Their product catalog includes specialized kits for monitoring blockbuster drugs in the fields of oncology and immunology. By leveraging proprietary technologies like chicken IgY production, the company provides high-specificity reagents for complex research and diagnostic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AffinityImmuno.